Cardiovascular and Obstetric Delivery Complications in Pregnant Women With Valvular Heart Disease

被引:7
作者
Minhas, Anum S. [1 ,2 ,6 ]
Rahman, Faisal [1 ,6 ]
Gavin, Nicole [3 ,6 ]
Cedars, Ari [1 ,6 ]
Vaught, Arthur Jason [3 ,6 ]
Zakaria, Sammy [1 ,6 ]
Resar, Jon [1 ,6 ]
Schena, Stefano [4 ,6 ]
Schulman, Steven [1 ,6 ]
Zhao, Di [5 ,6 ]
Hays, Allison G. [1 ,6 ]
Michos, Erin D. [1 ,6 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Dept Maternal Fetal Med, Sch Med, Baltimore, MD USA
[4] Johns Hopkins Univ, Div Cardiac Surg, Sch Med, Baltimore, MD USA
[5] Johns Hopkins Univ, Ciccarone Ctr Prevent Cardiovasc Dis, Sch Med, Baltimore, MD USA
[6] Johns Hopkins Univ, Baltimore, MD USA
关键词
LOW-DOSE ASPIRIN; OUTCOMES;
D O I
10.1016/j.amjcard.2021.07.038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Women with valvular heart disease may be more likely to have adverse obstetric and cardiovascular complications during pregnancy. Most current recommendations focus on stenotic lesions with less guidance regarding regurgitant lesions. We aimed to compare adverse events at delivery for women with various stenotic and regurgitant valvular diseases. We used the 2016 to 2018 National Inpatient Sample data to compare demographics, comorbidities, and obstetric and cardiovascular complications during delivery hospitalizations. After adjusting for clinical and socioeconomic factors, logistic regression was performed to investigate associations between valvular disease and outcomes. Among > 11.2 million deliveries, 20,349 were in women with valvular disease. Women with valvular disease were older, had longer length of stays, and higher costs associated with delivery. They had higher prevalence of underlying cardiovascular comorbidities compared with women without valvular disease (hypertension: 5.1 vs 0.25%; pulmonary hypertension: 7.0 vs < 0.1%). At delivery, they had higher adjusted odds of obstetric events including preeclampsia and/or eclampsia (aOR 1.9 [1.8 to 2.2]) and intrapartum/postpartum hemorrhage (aOR 1.4 [1.2 to 1.6]), and cardiovascular events including peripartum cardiomyopathy (aOR 65 [53 to 78]), pulmonary edema (aOR 17 [13 to 22]), acute ischemic heart disease (aOR 19 [12 to 30]) and arrhythmias (aOR 22 [19 to 27]). There were valve lesion-specific differences in the magnitude of risk but both stenotic and regurgitant lesions were associated with elevated risk of cardiovascular complications. In conclusion, pregnant women with stenotic and regurgitant valvular disease have a greater burden of cardiovascular comorbidities and increased odds of obstetric and cardiovascular events at delivery. These women may benefit from specialized care from a Cardio-Obstetrics team. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:90 / 97
页数:8
相关论文
共 50 条
  • [21] Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease
    Balci, Ali
    Sollie-Szarynska, Krystyna M.
    van der Bijl, Antoinette G. L.
    Ruys, Titia P. E.
    Mulder, Barbara J. M.
    Roos-Hesselink, Jolien W.
    van Dijk, Arie P. J.
    Wajon, Elly M. C. J.
    Vliegen, Hubert W.
    Drenthen, Willem
    Hillege, Hans L.
    Aarnoudse, Jan G.
    van Veldhuisen, Dirk J.
    Pieper, Petronella G.
    HEART, 2014, 100 (17) : 1373 - 1381
  • [22] Risk Factors for Cardiovascular Events among Pregnant Women with Cardiovascular Disease
    Nii, Masafumi
    Tanaka, Hiroaki
    Tanaka, Kayo
    Katsuragi, Shinji
    Kamiya, Chizuko A.
    Shiina, Yumi
    Niwa, Koichiro
    Ikeda, Tomoaki
    INTERNAL MEDICINE, 2020, 59 (09) : 1119 - 1124
  • [23] Management of Hypercholesterolemia in Pregnant Women with Atherosclerotic Cardiovascular Disease
    Thobani, Aneesha
    Hassen, Lauren
    Mehta, Laxmi S.
    Agarwala, Anandita
    CURRENT ATHEROSCLEROSIS REPORTS, 2021, 23 (10)
  • [24] Pregnancy complications and long-term risk of cardiovascular events in women with structural heart disease
    Cederlof, Elin Taufer
    Lindhagen, Lars
    Lundgren, Maria
    Lindahl, Bertil
    Christersson, Christina
    OPEN HEART, 2024, 11 (02):
  • [25] Maternal and Neonatal Outcomes in Pregnant Women With Congenital Heart Disease: The Magee Obstetric Maternal and Infant (MOMI) ACHD Substudy
    Saraf, Anita
    Patel, Jil
    Hindes, Morgan
    Berlacher, Kathryn
    Hoskoppal, Arvind
    Catov, Janet M.
    Kalogeropoulos, Andreas P.
    CIRCULATION, 2023, 148
  • [26] Predictors of maternal and neonatal complications in women with severe valvular heart disease during pregnancy in Tunisia: a retrospective cohort study
    Hammami, Rania
    Ibn Hadj, Mohamed Ali
    Mejdoub, Yosra
    Bahloul, Amine
    Charfeddine, Selma
    Abid, Leila
    Kammoun, Samir
    Dammak, Abdallah
    Chaabene, Kais
    BMC PREGNANCY AND CHILDBIRTH, 2021, 21 (01)
  • [27] Valvular heart diseases in women
    Youssef, Ghada
    EGYPTIAN HEART JOURNAL, 2021, 73 (01)
  • [28] Systemic Lupus Erythematosus and Pregnancy: An Analytical Review of Cardiovascular Disease and Obstetric Complications
    Hussain, Bilal
    Mahmood, Ahmed M.
    Alalawi, Luay
    Cuevas, Christel
    Khan, Sohail
    Waqar, Fahad
    Alexander, Thomas
    Ansari, Mohammad M.
    CIRCULATION, 2023, 148
  • [29] Ventricular efficiency in pregnant women with congenital heart disease
    Muneuchi, Jun
    Yamasaki, Keiko
    Watanabe, Mamie
    Fukumitsu, Azusa
    Kawakami, Takeshi
    Nakahara, Hiromasa
    Joo, Kunitaka
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 261 : 58 - 61
  • [30] Pregnant Women With Uncorrected Congenital Heart Disease Heart Failure and Mortality
    Sliwa, Karen
    Baris, Lucia
    Sinning, Christoph
    Zengin-Sahm, Elvin
    Gumbiene, Lina
    Yaseen, Israa F.
    Youssef, Ghada
    Johnson, Mark
    Al-Farhan, Hasan
    Lelonek, Malgorzata
    Hall, Roger
    Roos-Hesselink, Jolien
    JACC-HEART FAILURE, 2020, 8 (02) : 100 - 110